Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population

• Shujuan Ni,
• Shujuan Ni,
• Shujuan Ni,
• Xin Wang,
• Xin Wang,
• Xin Wang,
• Jinjia Chang,
• Jinjia Chang,
• Hui Sun,
• Hui Sun,
• Hui Sun,
• Weiwei Weng,
• Weiwei Weng,
• Weiwei Weng,
• Xu Wang,
• Xu Wang,
• Xu Wang,
• Cong Tan,
• Cong Tan,
• Cong Tan,
• Meng Zhang,
• Meng Zhang,
• Meng Zhang,
• Lei Wang,
• Lei Wang,
• Lei Wang,
• Zhaohui Huang,
• Dan Huang,
• Dan Huang,
• Dan Huang,
• Midie Xu,
• Midie Xu,
• Midie Xu,
• Weiqi Sheng,
• Weiqi Sheng,
• Weiqi Sheng

Affiliations

Shujuan Ni

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Shujuan Ni

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Shujuan Ni

Institute of Pathology, Fudan University, Shanghai, China

Xin Wang

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Xin Wang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Xin Wang

Institute of Pathology, Fudan University, Shanghai, China

Jinjia Chang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Jinjia Chang

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Hui Sun

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Hui Sun

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Hui Sun

Institute of Pathology, Fudan University, Shanghai, China

Weiwei Weng

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Weiwei Weng

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Weiwei Weng

Institute of Pathology, Fudan University, Shanghai, China

Xu Wang

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Xu Wang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Xu Wang

Institute of Pathology, Fudan University, Shanghai, China

Cong Tan

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Cong Tan

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Cong Tan

Institute of Pathology, Fudan University, Shanghai, China

Meng Zhang

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Meng Zhang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Meng Zhang

Institute of Pathology, Fudan University, Shanghai, China

Lei Wang

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Lei Wang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Lei Wang

Institute of Pathology, Fudan University, Shanghai, China

Zhaohui Huang

Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, China

Dan Huang

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Dan Huang

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Dan Huang

Institute of Pathology, Fudan University, Shanghai, China

Midie Xu

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Midie Xu

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Midie Xu

Institute of Pathology, Fudan University, Shanghai, China

Weiqi Sheng

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Weiqi Sheng

Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Weiqi Sheng

Institute of Pathology, Fudan University, Shanghai, China